Zepbound: FDA approves new weight-loss drug

United States News News

Zepbound: FDA approves new weight-loss drug
United States Latest News,United States Headlines
  • 📰 fox5ny
  • ⏱ Reading Time:
  • 41 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 20%
  • Publisher: 51%

Federal regulators say a new version of the popular diabetes treatment Mounjaro can be sold as a weight-loss drug.

The U.S. Food and Drug Administration approved Eli Lilly's drug, named Zepbound. The drug, also known as tirzepatide, helped dieters lose as much as 40 to 60 pounds in testing.

In another recent study, the drug helped people lose up to a quarter of their weight, or 60 pounds , when combined with intensive diet and exercise. Touted by celebrities and on social media, semaglutide and tirzepatide drugs have already been in such demand that their manufacturers have struggled to keep up. Both have been listed on the FDA’s drug shortage site for months. All strengths of tirzepatide are currently listed as available, but a company spokesperson said that could vary by location and demand.

"Most patients won't be able to afford Zepbound without insurance coverage and many health plans exclude obesity care," said Dr. Katherine Saunders, an obesity expert at New York's Weill Cornell Medicine and co-founder of company focused on obesity treatment.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

fox5ny /  🏆 587. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Zepbound: FDA approves new version of diabetes drug Mounjaro for weight lossZepbound: FDA approves new version of diabetes drug Mounjaro for weight lossThe U.S. Food and Drug Administration on Wednesday approved a new version of the type 2 diabetes drug tirzepatide for use in chronic weight management, officials said.
Read more »

New weight loss drug: FDA approves Zepbound, a version of diabetes drug Mounjaro for obesityNew weight loss drug: FDA approves Zepbound, a version of diabetes drug Mounjaro for obesityZepbound, a new version of the popular diabetes treatment Mounjaro, can now be sold as a weight-loss drug and helped patients lose 25% of their weight.
Read more »

FDA approves new version of diabetes drug Mounjaro for weight lossFDA approves new version of diabetes drug Mounjaro for weight lossSetting—and sticking to—a holiday budget could help you avoid finical hardship down the road.
Read more »

FDA approves new version of diabetes drug Mounjaro for weight lossFDA approves new version of diabetes drug Mounjaro for weight lossEven though multiple suspects have been captured on camera, so far police haven't been able to catch the crooks.
Read more »

FDA approves new diabetes drug Mounjaro for weight lossFDA approves new diabetes drug Mounjaro for weight lossA new diabetes drug has been approved by the US Food and Drug Administration for use as a weight-loss drug.
Read more »

FDA approves new version of diabetes drug Mounjaro for weight lossFDA approves new version of diabetes drug Mounjaro for weight lossBucyrus City Schools canceled classes on Wednesday after the district's superintendent said a bomb threat was made toward the schools.
Read more »



Render Time: 2025-02-12 00:15:00